Latest News
- Rezolute Announces $25 Million Private Placement -- Potential Total Investment of $45 Million
- Rezolute Announces Appointment of Keith Vendola as Chief Financial Officer
- Rezolute Announces Appointment of Congenital Hyperinsulinism Therapeutic Area Expert, Dr. Christine Ferrara, as Director of Clinical Development